← Leaderboards
James Kelly
Weill Medical Coll Of Cornell Univ
$949,737
Attributed
$1,068,599
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $489.1K · FY2020–22$500K$375K$250K$125K$0
'20
'21
'22
Funding mix
By agency
NIH$1,068,599 · 2
By mechanism
R21$1,068,599 · 2
Top collaborators
- John W Babich1 shared
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Benedict Shek Hang Law$4,167,074
- Justin Roy Kingery$387,720
- Claire Isabelle Vanpouille-Box$2,058,782
- Angela Montero$49,538
Others in their field
Other Emerging Leaders on “Tracer”
- Suzanne L Baker · University Of Pittsburgh At Pittsburgh$20,555,546
- Tharick Pascoal · University Of Pittsburgh At Pittsburgh$20,555,546
- Zhengxin Cai · Yale University$10,214,567
- Daniel R Wahl · University Of Michigan At Ann Arbor$5,791,541
- Joshua William Cates · University Of Calif-Lawrenc Berkeley Lab$5,484,762
- Gloria Chia-Yi Chiang · Weill Medical Coll Of Cornell Univ$5,402,243
Research focus
TracerImaging BiomarkerMitochondriaResolutionMonitorPositron-Emission TomographyEvaluationImaging TechniquesProceduresRadiolabeledClinical ImagingUptakeDiagnosisBiological MarkersClinicEnzymesImageDiagnosticAndrogen SensitiveCancer CellAlanineAndrogensD-Amino Acid DehydrogenaseDeprivation
Grant awards (5)
The Development of Radiolabeled Positional isomers of [11C]Pyruvate for Imaging Cancer Metabolism$211,875
R21 · FY2022 · EB · contact PI
PET Imaging Biomarkers to Predict Cardiac Remodeling and Functional Decline in Cardiotoxicity Arising from Chemotherapy$198,103
R21 · FY2021 · CA · contact PI
The Development of Radiolabeled Positional isomers of [11C]Pyruvate for Imaging Cancer Metabolism$169,500
R21 · FY2021 · EB · contact PI
The Development of Radiolabeled Positional isomers of [11C]Pyruvate for Imaging Cancer Metabolism$251,397
R21 · FY2020 · EB · contact PI
PET Imaging Biomarkers to Predict Cardiac Remodeling and Functional Decline in Cardiotoxicity Arising from Chemotherapy$237,724
R21 · FY2020 · CA · contact PI